222C2237 FR0011799907-FS0765
September 22, 2022
Declaration of threshold crossing (Article L. 233-7 of the Commercial Code)
IT IS REMINDERED THAT THIS DECLARATION IS DRAWN UP UNDER THE RESPONSIBILITY OF THE DECLARER, THE
PUBLICATION OF THIS NOTICE DOES NOT IMPLY VERIFICATION BY THE AMF OF THE INFORMATION PROVIDED.
GENOMIC VISION
(Euronext Paris)
In a letter received on September 22, 2022, Mr. Bruno Chalom Sayada declared having crossed directly and indirectly upwards, on September 21, 2022, the thresholds of 5% of the capital and voting rights of the company GENOMIC VISION and to hold, directly and indirectly, through Valentin Capital Management companies1 and Advanced Biological Laboratories SA1 that it controls, 4,496,370 GENOMIC VISION shares representing as many voting rights, i.e. 6.50% of the capital and voting rights of this company2distributed as follows :
Shares and voting rights | % capital and voting rights | ||||
Valentin Capital Management | 2,308,085 | 3.34 | |||
Advanced Biological Laboratories | 1,538,285 | 2.22 | |||
Mr. Bruno Chalom Sayada | 650,000 | 0.94 | |||
Total Mr. Bruno Chalom Sayada | 4,496,370 | 6.50 |
This crossing of thresholds results from an acquisition of GENOMIC VISION shares on the market.
________
-
Société anonyme under Luxembourg law (located 52-54 avenue du X Septembre, L 2550, Luxembourg) controlled by Mr. Bruno Chalom Sayada.
2 On the basis of a capital composed of 69,181,364 shares representing as many voting rights (according to the declarant), pursuant to 2th paragraph of article 223-11 of the general regulations.
222C2237-FR0011799907-FS0765
Disclaimer
Genomic Vision SA published this content on September 23, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on September 23, 2022 09:09:07 UTC.